Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses

SN Crooke, IG Ovsyannikova, GA Poland… - Experimental …, 2019 - Elsevier
Immunosenescence contributes to a decreased capacity of the immune system to respond
effectively to infections or vaccines in the elderly. The full extent of the biological changes …

Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery

S Ekins, JS Freundlich, I Choi, M Sarker, C Talcott - Trends in microbiology, 2011 - cell.com
We are witnessing the growing menace of both increasing cases of drug-sensitive and drug-
resistant Mycobacterium tuberculosis strains and the challenge to produce the first new …

Systems biology of fungal infection

F Horn, T Heinekamp, O Kniemeyer… - Frontiers in …, 2012 - frontiersin.org
Elucidation of pathogenicity mechanisms of the most important human-pathogenic fungi,
Aspergillus fumigatus and Candida albicans, has gained great interest in the light of the …

Tuberculosis: current status, diagnosis, treatment and development of novel vaccines

J Yadav, S Verma, D Chaudhary… - Current …, 2019 - ingentaconnect.com
Tuberculosis (TB) is an infectious disease that mainly affects the lungs and spreads to other
organs of the body through the haematogenous route. It is one of the ten major causes of …

Systems biology approaches to investigate the role of granulomas in TB-HIV coinfection

A Hoerter, E Arnett, LS Schlesinger… - Frontiers in …, 2022 - frontiersin.org
The risk of active tuberculosis disease is 15-21 times higher in those coinfected with human
immunodeficiency virus-1 (HIV) compared to tuberculosis alone, and tuberculosis is the …

A physiologically based pharmacokinetic model of rifampin in mice

MA Lyons, B Reisfeld, RSH Yang… - Antimicrobial agents …, 2013 - Am Soc Microbiol
One problem associated with regimen-based development of antituberculosis (anti-TB)
drugs is the difficulty of a systematic and thorough in vivo evaluation of the large number of …

[HTML][HTML] Mycobacterial virulence: Impact on immunogenicity and vaccine research

VM Kroesen, J Madacki, W Frigui, F Sayes… - …, 2019 - ncbi.nlm.nih.gov
The borderline between virulence and efficacy in live attenuated vaccine strains is often
blurred and this is also the case for the Bacillus Calmette–Guérin (BCG), the only currently …

Systems approach to tuberculosis vaccine development

CC Wang, B Zhu, X Fan, B Gicquel, Y Zhang - Respirology, 2013 - Wiley Online Library
Tuberculosis is both highly prevalent across the world and eludes our attempts to control it.
The current bacillus C almette–G uérin vaccine has unreliable protection against adult …

A brief overview of mathematical modeling of the within-host dynamics of Mycobacterium tuberculosis

D Chakraborty, S Batabyal… - Frontiers in Applied …, 2024 - frontiersin.org
Tuberculosis (TB), a disease caused by bacteria Mycobacterium tuberculosis (Mtb), remains
one of the major infectious diseases of humans with 10 million TB cases and 1.5 million …

On the way toward systems biology of Aspergillus fumigatus infection

D Albrecht, O Kniemeyer, F Mech, M Gunzer… - International Journal of …, 2011 - Elsevier
Pathogenicity of Aspergillus fumigatus is multifactorial. Thus, global studies are essential for
the understanding of the infection process. Therefore, a data warehouse was established …